GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is currently gaining a significant focus in medical investigation, largely due to its remarkable impact on controlling ailments such as second type diabetes and weight gain. New trials have demonstrated that in addition to glucose management, GLP-1 drugs offer potential for circulatory wel